Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Article on the Dangers of Chloramphenicol in Milk and Its Detection

Published: Tuesday, July 02, 2013
Last Updated: Tuesday, July 02, 2013
Bookmark and Share
An article exploring the dangers posed by chloramphenicol (CAP) in milk and its detection using the EVOQ Qube LC-TQ MS/MS is described.

The article entitled “The Danger of Chloramphenicol in Milk” from the Bruker Chemical & Applied Markets (CAM) division has been published in Food Safety Magazine online. Authored by Bruker specialists in liquid chromatography, the article examines the dangerous effects of CAP in contaminated food and how the high sensitivity EVOQ can detect levels as low as 0.02 ppb in milk, far exceeding minimum required performance levels (MRPL) set by EU guidelines.
 
Chloramphenicol is a naturally occurring broad spectrum antibiotic, initially employed as a first line of treatment for typhoid. Although CAP is still commonly prescribed as an optical treatment in the EU, its use is otherwise severely limited. This is in part due to the risk the drug poses to infants, who lack the fully developed liver enzymes to metabolize the drug. Ingestion of CAP can thus cause potentially fatal Gray Baby syndrome, and has also been linked to acute lymphotic leukemia and bone marrow suppression.
 
Consequently in the EU chloramphenicol is banned from use in veterinary medicine and its presence in food products such as milk is strictly prohibited. Regulations state that methods used for the detection of CAP in milk must meet or exceed the MRPL of 0.3 ppb. A case study was carried out on the EVOQ Qube LC-TQ MS/MS, designed for maximum sensitivity in high throughput applications. The EVOQ was able to quantify concentrations as low as 0.2 ppb, easily exceeding EU guidelines, while maintaining consistent ion rations from 0.05 to 1.0 ppb.
 
“Routine food testing requires sustained high sensitivity and the fastest possible turnaround, since time can be critical,” Meredith Conoley, Marketing Director for Bruker CAM, said. “The EVOQ was specifically designed with new technological innovations to meet these criteria. The Active Exhaust prevents the recirculation of nebulized gases to reduce chemical build up, while the Orifice Interface is continually flushed to keep it clean and reduce instrument downtime. PACER exception based data review software moreover provides the fastest sample to report time possible. This high performance instrument offers advantages for many application areas, including environmental testing and forensics.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
10X Genomics Releases Linked-Read Data from NIST Genome Samples
Genome in a Bottle Consortium data submission for webinar presentation and public availability.
Study Sheds Light on the Causes of Cerebral Palsy
Wider use of genetic testing in children with CP should be considered.
Pitt Researchers to Monitor Resistance to HIV Drugs in Africa
Infectious diseases researchers from the University of Pittsburgh School of Medicine are leading a five-year, $5 million initiative to monitor drug resistance during the rollout of HIV prevention drugs in sub-Saharan Africa.
Environmental Epigenetics Affects Disease, Evolution
Researchers say environmental factors are having an underappreciated effect on the course of disease and evolution by prompting genetic mutations through epigenetics, a process by which genes are turned on and off independent of an organism’s DNA sequence.
Critical New Insights on DNA Repair
The enzyme fumarase is key to reversing genetic damage leading to cancer and therapy resistance.
Potential Treatment for Muscular Dystrophy
A new method for producing muscle cells could offer a better model for studying muscle diseases, such as muscular dystrophy, and for testing potential treatment options.
Nanoparticles Used to Breach Mucus Barrier in Lungs
Proof-of-concept study conducted in mice is a key step toward better treatments for lung diseases.
New Biosensors for Managing Microbial ‘Workers’
Researchers at Harvard’s Wyss Institute have unveiled new biosensors that enable scientists to more effectively control and 'communicate with' engineered bacteria.
Researchers Identify Protein in Mice that Helps Prepare for Healthy Egg-sperm Union
Protein RGS2 plays a critical role in preserving the fertilizability of the ovulated egg.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!